SimpleTrials
Private Company
Funding information not available
Overview
Founded in 2015 and headquartered in San Francisco, SimpleTrials is a private, revenue-generating software-as-a-service (SaaS) company in the clinical operations technology sector. Its core offering is a validated, integrated CTMS and eTMF platform delivered via a subscription model, targeting the need for affordable and scalable clinical trial management tools among small to mid-sized biotechs, CROs, and sites. The company has demonstrated significant growth, including an 85% year-over-year revenue increase in 2023, and is expanding its ecosystem through technology partnerships, such as its recent verification with the EDC provider Viedoc.
Technology Platform
Cloud-based, validated Software-as-a-Service (SaaS) platform integrating Clinical Trial Management System (CTMS) and electronic Trial Master File (eTMF) functionalities, featuring pay-as-you-go subscription, built-in workflows, and EDC integration capabilities.
Opportunities
Risk Factors
Competitive Landscape
SimpleTrials competes in a fragmented market against large enterprise players (e.g., Veeva, Medidata, Oracle) and other niche CTMS/eTMF providers. Its primary differentiation is a low-cost, subscription-based SaaS model focused on simplicity and flexibility for small-to-mid-sized clients, contrasting with complex, high-cost enterprise systems.